Wolverine Asset Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,000
Closed -$21K 2701
2021
Q4
$21K Buy
+1,000
New +$19.7K ﹤0.01% 1711

Other funds holding OCDX

Wolverine Asset Management's OCDX Position: Q1 2022 in Review

Wolverine Asset Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 1,000 shares — an estimated $21K sold.

Wolverine Asset Management first reported a position in OCDX in Q4 2021 and held it in 1 quarter. The position peaked at $21K in Q4 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Wolverine Asset Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 1,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $21K.
  • Wolverine Asset Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 1 quarter.
  • Wolverine Asset Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $21K in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Wolverine Asset Management's 13F filing for Q1 2022, filed 4 May 2022.